Members do not see these Ads. Sign Up.

Netizens

The Tacticon ™ is a small, hand held, passive medical device that the FDA has recently allowed to be marketed to screen patients for evidence of subclinical peripheral neuropathy of the fingers and toes. The Tacticon ™ permits quantitative sensory testing (QST) as recommended by the American Diabetes Association Consensus Panels on Diabetic Peripheral Neuropathy. Doesanyone have any clinical experiences of this tool?


Appreciated

Cameron